Background: Pacemakers (PM) are used for managing sick sinus syndrome (SSS). This study evaluates predictors and trends of PM implantation for SSS.
INTRODUCTION
Sick sinus syndrome (SSS) is a constellation of findings characterized by abnormal sinoatrial nodal function, resulting in symptomatic bradyarrhythmias, and often associated with recurrent tachyarrhythmias (atrial fibrillation). 1 Annual incidence of SSS in individuals 45 years and older is close to one per 1,000 2 and approximately 49% are women and 17% are non-Caucasian. 3, 4 Pacemaker (PM) implantation has increased between 1993 and 2009 5 and is commonly used for treatment of SSS. However, racial, 6, 7 gender, 8, 9 and hospital 9 disparities have been reported to present barriers to PM implantation. The purpose of this study, therefore, is to query, over an 11-year period 
METHODS

Data source
defined as having a primary diagnostic ICD-9 code of sinoatrial node dysfunction (427.81) complicated with any code of atrial fibrillation Patients who satisfied these inclusion and exclusion criteria (i.e., diagnosis of SSS) were then stratified by PM implantation and a comparison between those who did versus those who did not receive a PM was performed to assess variables that may impact utilization of device therapy. This protocol was approved by the Ohio State University Institutional Review Board.
PM definition
Cardiac implantable electronic devices included only single and dual chamber PM. Patients who received PM during hospitalization were determined by corresponding ICD-9 procedure codes of device implantation (37.80, 37.81, 37.82, 37.83).
Patient variables
Patient variables that were collated, using ICD-9 diagnostic codes, included: age, gender, race, smoking status, insurance type, admission type, admission time, length of stay, household income, hyperlipidemia, hypertension, coronary artery disease (CAD), chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), and comorbidities and comorbidity score. To represent the overall health status, comorbidity score was calculated using the updated version of Charlson index. Household income was defined as the median household income of the community in which the patient resided.
Hospital variables
Several hospital characteristics that may have an impact on accessibility of PM implantation were included in analysis. Hospitals were classified as public or private, and as rural, urban nonteaching, or urban teaching. The region of hospital location within the US was classified as Northeast, Midwest, West, or South. Hospital size was classified as small, medium or large according to the number of beds. In addition, cardiac procedure volume and cardiology inpatient volume were collated. Cardiac procedure volume was estimated from the number of visits that have at least one cardiac procedure code and was adjusted by the trend weight. The cardiology inpatient volume was estimated from the total number of visits with cardiovascular disease as the primary diagnosis and adjusted by the trend weight. Also, cost per hospitalization was collected.
Statistical methods
All descriptive measures reported in this article were estimated using sampling weight. The temporal distribution of PM implantation rates is presented per year. Total number of SSS admissions and PM implantation procedures were obtained from trend weight. The trend weight accounts for both the multistage stratified sampling and the comparability across different years. The temporal trend of annual PM implantation rate in SSS patients were described using line plots and stratified by device types. Further line plot was drawn for average hospital cost for device implantation. The trends of categorical variables were tested using the Cochrane Armitage test, while the trends of continuous variables were tested by t tests for the linear slopes. Demographics were presented with categorical variables analyzed using weighted chi-square tests, while means were compared using t-tests appropriate for multistage sampling.
In multivariable analyses, continuous variables were categorized.
Odds ratios (ORs) and 95% confident intervals (CIs) of all explanatory variables using multiple logistic regression models are provided. Discharge weight was used in the model to account for the multistage sampling effect. Patient and hospital variables were included in the final model and the ORs, CIs, and P values are presented. The P value for this analysis was set at 0.05.
Interaction terms (male vs. female sex, white vs. non-white race, private vs. public insurance type, teaching vs. nonteaching hospital) were added to multivariable models to compare the OR of risk factors. The level of significance for P statistics was set to be 0.05. All analyses were conducted in SAS 9.4 software (SAS Institute Inc., Cary, NC, USA).
RESULTS
Study population
During the year 2003-2013, there were 433,845 inpatient admissions for SSS, accounting for 0.1% of 424 million hospitalizations in the United States. After accounting for the exclusion factors, 328,670 patients were diagnosed with SSS in whom PM was implanted in 87.4% (n = 287,412). These patients who did receive a PM were then compared to 41,258 SSS patients who did not undergo device implantation (Table 1 ). The mean age for the study population was 77.5 years, 54.2% were female, 71.3% were white, 87% were Medicare/Medicaid insured and there was similar (∼23-26% each) distribution among all income groups.
Temporal patterns
The has increased over the years ( slope = 2655, P < 0.001; Fig. 2 ).
Univariate analysis SSS patients: With versus those without PM
The distribution of all collated variables was statistically different among patients with compared to those without PM implantation, except for smoking history and hypertension. (Table 1 ). 
Multivariate analysis of patient variables associated with PM implantation (
Gender
Female patients were more likely to have PM implantation at a younger age. In addition, white patients were more likely to have 
TA B L E 3 Multivariate analysis of hospital features of SSS patients associated with pacemaker implantation
Race
Non-white younger patients (age 41-65) were more likely to have implantation compared to non-white older patients, whereas such association was reversed in white patients. Hospital teaching status and household income impacted PM implantation only in non-white patients. Besides, the negative association between Charlson comorbidity score and implantation was higher in magnitude in non-white patients.
Insurance
Insurance type may modify the effect of patient level characteristics.
Young patients were less likely to obtain a device in both insurance 
Teaching hospital
White patients have higher likelihood of getting a device, especially in a teaching hospital. Medicare or Medicaid beneficiaries in teaching hospital were more likely to obtain an implantation, whereas such group of patients were less likely to be implanted in nonteaching hospitals.
However, the comorbidity score and household income of patients has no heterogeneous effect among patients hospitalized in teaching and nonteaching hospitals. 
TA B L E 4 Odds ratios of pacemaker implantation by multivariate analysis stratified by gender
DISCUSSION
The current study was designed to identify the relevant factors asso- non-Caucasians, and Medicare/Medicaid patients are less likely to be treated with a PM for SSS. Despite prior publications reporting racial 6, 7 and gender 8, 9 bias to PM implantation, the findings of the current study suggest that these biases are unchanged and persist through 2013. Multiple studies have reported that non-Caucasian populations have lower rates of receiving PM. 6, 7, 9, [11] [12] [13] [14] Similarly, gender disparity has reported lower PM implantation in women. 7, 8, 11, [14] [15] [16] [17] The current study demonstrates similar racial and sexual disparity in the SSS population with reduced utilization in non-Caucasians and females. The explanation for this finding is likely multifactorial. Multivariate analysis suggests that lower household income is associated with reduced PM implantation among non-whites 14, 18 yet, patients with Medicare/Medicaid insurance were not underserved. Also, even though women and non-Caucasian race are less likely to have PM implant compared to men and white race, respectively, it was noticed that younger patients in this underserved population were more likely to get implanted than the older patients. We are unable to find a reason for this practice except that this might indicate less comorbidities in younger patients, which makes them better candidates for PM implan- Finally, the emergence of wearable heart rate monitoring devices in 2008 may have increased awareness of heart rate. 21 Although it is obvious why high procedure volume was associated with higher device implantation, it is more challenging to reconcile the lower likelihood of PM utilization with high inpatient volumes. We can hypothesize that this is related to movement towards a value based system in which hospitals with high inpatient volumes unload procedures for lower cost to outpatient setting in turn reducing hospitalization cost and overall costs. 22 We found negative association of emergency and weekend admission with device implantation. We think these data are supported by negative health and economic outcomes [23] [24] [25] with emergency and weekend stays shown before. This data supports the hypothesis of value-based care 22 given outpatient treatment in times when it is clinically appropriate, is cost efficient, and is associated with better outcomes overall. Medicare/Medicaid insurance status leads to PM implantation at an older age with no effect of hospital ownership or comorbidity score (contrary to nonstratified analysis). Also, this is the first report that compared public and private insurance that found patients' age, sex, and socioeconomic status give directional relationship to PM utilization when patient had private or public insurances.
TA B L E 5
TA B L E 7
Stratified analysis of teaching versus nonteaching hospitals revealed higher likelihood of receiving a device at a younger age and, with Medicare/Medicaid insurance there is equal likelihood of receiving a device at public teaching institution. These findings are novel and contrary to finding in the nonstratified cohort and supported by studies comparing teaching and nonteaching hsopitals. 27,28
Limitations
Despite the advantages of using the largest inpatient database in the United States, it still is limited by being solely classified by ICD-9
codes. Such a dataset does not contain comprehensive medical history (including echocardiographic parameters) relevant to the SSS patient.
Also, we defined SSS (sinoatrial node dysfunction and atrial arrhythmias) in a way that we include a pure sample which definitely led to attenuation of sample size. However, given the power derived from current sample size directionality of relationships and trends was not affected. Also, reasons to explain temporal trends and treatment bias cannot be evaluated.
Conclusion
Using the NIS database, the present study demonstrates that inpatient 
